These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21031002)

  • 1. The importance of new companies for drug discovery: origins of a decade of new drugs.
    Kneller R
    Nat Rev Drug Discov; 2010 Nov; 9(11):867-82. PubMed ID: 21031002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of innovation: an assessment of intellectual property.
    Kinch MS; Raffo J
    Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A forensic analysis of drug targets from 2000 through 2012.
    Munos B
    Clin Pharmacol Ther; 2013 Sep; 94(3):407-11. PubMed ID: 23756372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased contribution of small companies to late-entry drugs: a changing trend in FDA-approved drugs during the 2020s.
    Okuyama R
    Drug Discov Today; 2024 Feb; 29(2):103866. PubMed ID: 38145871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade in drug discovery.
    Nat Rev Drug Discov; 2012 Jan; 11(1):3. PubMed ID: 22329019
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of original research contributions toward FDA-approved drugs.
    Patridge EV; Gareiss PC; Kinch MS; Hoyer DW
    Drug Discov Today; 2015 Oct; 20(10):1182-7. PubMed ID: 26113307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from 60 years of pharmaceutical innovation.
    Munos B
    Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the priority review voucher program stimulating new drug development for tropical diseases?
    Kerr KW; Henry TC; Miller KL
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006695. PubMed ID: 30092022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining Manufacturing Readiness for Breakthrough Drug Development.
    Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
    AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving drug discovery: the fundamental role of academic labs.
    Silber BM
    Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987-2011.
    Lanthier M; Miller KL; Nardinelli C; Woodcock J
    Health Aff (Millwood); 2013 Aug; 32(8):1433-9. PubMed ID: 23918488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening the Competitiveness of Japan's Pharmaceutical Industry: Analysis of Country Differences in the Origin of New Drugs and Japan's Highly Productive Firm.
    Okuyama R
    Biol Pharm Bull; 2023; 46(5):718-724. PubMed ID: 37121698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2018 in review: FDA approvals of new molecular entities.
    Kinch MS; Griesenauer RH
    Drug Discov Today; 2019 Sep; 24(9):1710-1714. PubMed ID: 31158510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in pharmaceutical targeting of clinical indications: 1930-2013.
    Kinch MS; Merkel J; Umlauf S
    Drug Discov Today; 2014 Nov; 19(11):1682-1685. PubMed ID: 24881779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deconstructing the drug development process: the new face of innovation.
    Kaitin KI
    Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2017 in review: FDA approvals of new molecular entities.
    Kinch MS; Griesenauer RH
    Drug Discov Today; 2018 Aug; 23(8):1469-1473. PubMed ID: 29751111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The productivity crisis in pharmaceutical R&D.
    Pammolli F; Magazzini L; Riccaboni M
    Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.